by admin | Apr 19, 2024 | Article
January 24, 2024 – “As the world continues its return to pre-pandemic norms, many immunocompromised Canadians are still struggling to feel safe. Why aren’t we doing more for those left behind?” Please visit Left Behind: Immunocompromised Canadians Living in...
by admin | Apr 19, 2024 | Article
February 14, 2024 – “In the spring of 2022, even as COVID-19 restrictions were being lifted across the country (and the world), there was still a great deal of concern from immunocompromised patients about how they navigate the ‘post-pandemic world’. In response...
by admin | Apr 19, 2024 | Article
Dr. Joan Wither Senior Scientist, Krembil Research Institute Professor of Medicine and Immunology, University of Toronto Director of STAT (Urgent Assessment) Rheumatology Clinic, Toronto Western Hospital Director of Early Autoimmune Rheumatic Disease Clinic, Toronto...
by admin | Apr 19, 2024 | Article
Now Enrolling People with Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN) For A Research Study Study Title:Phase 2 ALXN1210-NEPH-202 Study (clinicaltrials.gov NCT04564339) Study Sponsor:Alexion, Astra Zeneca Rare Disease Purpose of Study:The purpose of...
by admin | Apr 19, 2024 | Article
As provincial governments begin their rollout plans for the COVID-19 vaccine we encourage you to speak with your healthcare team or...
by admin | Apr 19, 2024 | Article
https://www.lupuscanada.org/wp-content/uploads/AZD1222_PhIII-US-HLR_RNS.pdf
